Phenobarbital Tablet shortage
To Be Discontinued 8 presentations · 1 manufacturers · first FDA posting Oct 31, 2025 · last update Oct 31, 2025
Manufacturers: Endo Pharmaceuticals, Inc.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Phenobarbital, Tablet, 16.2 mg (NDC 0603-5165-21) | Endo Pharmaceuticals, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Oct 31, 2025 Updated Oct 31, 2025 Discontinued Oct 31, 2025 |
| Phenobarbital, Tablet, 16.2 mg (NDC 0603-5165-32) | Endo Pharmaceuticals, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Oct 31, 2025 Updated Oct 31, 2025 Discontinued Oct 31, 2025 |
| Phenobarbital, Tablet, 32.4 mg (NDC 0603-5166-21) | Endo Pharmaceuticals, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Oct 31, 2025 Updated Oct 31, 2025 Discontinued Oct 31, 2025 |
| Phenobarbital, Tablet, 32.4 mg (NDC 0603-5166-32) | Endo Pharmaceuticals, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Oct 31, 2025 Updated Oct 31, 2025 Discontinued Oct 31, 2025 |
| Phenobarbital, Tablet, 64.8 mg (NDC 0603-5167-21) | Endo Pharmaceuticals, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Oct 31, 2025 Updated Oct 31, 2025 Discontinued Oct 31, 2025 |
| Phenobarbital, Tablet, 64.8 mg (NDC 0603-5167-32) | Endo Pharmaceuticals, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Oct 31, 2025 Updated Oct 31, 2025 Discontinued Oct 31, 2025 |
| Phenobarbital, Tablet, 97.2 mg (NDC 0603-5168-21) | Endo Pharmaceuticals, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Oct 31, 2025 Updated Oct 31, 2025 Discontinued Oct 31, 2025 |
| Phenobarbital, Tablet, 97.2 mg (NDC 0603-5168-32) | Endo Pharmaceuticals, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Oct 31, 2025 Updated Oct 31, 2025 Discontinued Oct 31, 2025 |